#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15022	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2243	667.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1498	1498	C	844	C,A	791,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28112	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3658	767.1	0	.	n	.	0	T695C	SNP	695	695	T	1036	1036	C	885	C	806	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28112	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3658	767.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1678	1678	A	935	A,G	859,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28112	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3658	767.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2312	2312	C	861	C,G,T	797,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28112	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3658	767.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2386	2386	A	871	A	804	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28112	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3658	767.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2938	2938	C	878	C	821	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28112	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3658	767.1	0	HET	.	.	.	C2403T	.	2403	2403	C	2744	2744	C	866	C,T	639,168	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2012	folP	855	855	100.0	folP.l15.c4.ctg.1	1399	143.0	1	SNP	p	R229S	1	.	.	685	687	AGC	935	937	AGC	189;192;193	A;G;C	173;173;173	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5354	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3634	147.0	1	SNP	p	S91F	1	.	.	271	273	TTC	670	672	TTC	183;182;179	T;T;C	169;169;166	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5354	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3634	147.0	1	SNP	p	D95G	1	.	.	283	285	GGC	682	684	GGC	178;178;177	G,A;G;C	164,1;164;165	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5354	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3634	147.0	1	SNP	p	G95N	0	.	.	283	285	GGC	682	684	GGC	178;178;177	G,A;G;C	164,1;164;165	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1714	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1427	119.9	1	SNP	p	G45D	0	.	.	133	135	GGC	523	525	GGC	218;220;221	G;G;C	199;204;206	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	848	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1110	76.2	0	.	n	.	0	A197.	DEL	197	197	A	628	628	A	198	A	183	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5200	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2836	182.5	1	SNP	p	D86N	0	.	.	256	258	GAC	509	511	GAC	205;205;205	G;A;C	194;191;193	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5200	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2836	182.5	1	SNP	p	S87R	1	.	.	259	261	CGT	512	514	CGT	207;208;207	C;G;T	195;195;191	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5200	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2836	182.5	1	SNP	p	R87I	0	.	.	259	261	CGT	512	514	CGT	207;208;207	C;G;T	195;195;191	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5200	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2836	182.5	1	SNP	p	R87W	0	.	.	259	261	CGT	512	514	CGT	207;208;207	C;G;T	195;195;191	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5200	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2836	182.5	1	SNP	p	S88P	0	.	.	262	264	TCC	515	517	TCC	208;208;207	T,C;C;C	194,1;195;194	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4340	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2588	166.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1489	1491	GGC	229;227;229	G;G;C	210;207;209	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1268	1270	GCA	212;208;207	G;C,G;A	196;194,1;197	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1271	1273	ATC	210;210;214	A;T;C	197;197;201	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1283	1285	GTG	205;205;205	G;T;G	196;193;194	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1283	1285	GTG	205;205;205	G;T;G	196;193;194	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1787	1789	ACC	204;204;205	A;C;C	181;184;186	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1841	1843	GCG	195;194;197	G;C;G	173;159;163	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1841	1843	GCG	195;194;197	G;C;G	173;159;163	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1964	1966	AGC	141;138;137	A;G;C	130;127;127	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1973	1975	GGC	133;133;134	G;G;C	123;121;123	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4022	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	165.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1991	1993	CCG	127;131;129	C,G;C;G	95,5;99;101	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5752	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3135	183.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1683	1685	CCG	201;205;208	C;C;G	183;194;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2344	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1819	128.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	578	578	C	165	C	149	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	426	428	GTT	235;236;236	G;T;T	225;225;224	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	N121S	NONSYN	361	363	AAC	654	656	AGC	178;177;175	A;G;C	165;169;168	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	657	659	AAA	180;181;181	A;A;A	171;173;173	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	684	686	TAT	213;213;212	T;A;T	201;201;200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	N134E	NONSYN	400	402	AAT	693	695	GAG	211;209;208	G;A;G	198;195;196	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	V135L	NONSYN	403	405	GTG	696	698	CTT	210;215;217	C,A;T;T	195,1;203;203	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	G140K	NONSYN	418	420	GGA	711	713	AAA	223;222;223	A;A;A	209;209;209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	720	722	GAA	215;215;213	G;A;A	201;198;199	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	744	746	GCA	232;234;234	G;C;A	209;212;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	K207_M208insK	INS	619	619	A	912	912	A	234	A	216	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	A212S	NONSYN	634	636	GCA	930	932	TCA	232;230;226	T;C;A	213;213;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1660	162.3	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1047	1047	T	202	T	188	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10462	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4808	216.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1122	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1025	108.1	1	SNP	p	V57M	1	.	.	169	171	ATG	575	577	ATG	220;219;215	A;T;G	207;207;202	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
